Effect of age on drug metabolism in women with breast cancer
- 4 May 2015
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 11 (5) , 757-766
Abstract
Introduction: The aging of the population will increase the number of breast cancer patients requiring treatment in both the adjuvant and metastatic setting. Hormones, chemotherapy and targeted dru...Keywords
This publication has 97 references indexed in Scilit:
- Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trialEuropean Journal of Cancer, 2013
- A merican G eriatrics S ociety Updated B eers C riteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast CancerNew England Journal of Medicine, 2012
- Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?British Journal of Cancer, 2011
- Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840Annals of Oncology, 2011
- Effects ofCYP2D6genotypes on age‐related change of flecainide metabolism: involvement of CYP1A2‐mediated metabolismBritish Journal of Clinical Pharmacology, 2009
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerNew England Journal of Medicine, 2009
- Identification and Exploration of Herb-Drug Combinations Used By Cancer PatientsIntegrative Cancer Therapies, 2009
- Clinical pharmacology of cancer therapies in older adultsBritish Journal of Cancer, 2008